Prot#A6261008: A Randomized, Subject and Investigator-Blinded (Sponsor-Open), Placebo-Controlled Dose Escalation Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of Multiple Doses of PD 0360324 in Subjects with Active Cutaneous Lupus E

Project: Research project

Project Details

StatusFinished
Effective start/end date10/21/11 → 10/21/14

Funding

  • Parexel (A6261008 // A6261008)
  • Pfizer Inc. (A6261008 // A6261008)